Are you a journalist?

Get to know ALK

If you have any queries please feel free to contact Media Relations at ALK headquarters or one of our global offices.

The press releases in this press room contains information that is of general news value for the press, and available for journalists or media with a view to journalistic assessment and preparation before publication.


  • Post date
    Germany becomes first launch market for ALK’s tree SLIT-tablet
  • Post date
    Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
  • Post date
    Six-month interim report (Q2) 2019
  • Post date
    ALK upgrades its full-year financial outlook due to strong growth
  • Post date
    ALK announces new epinephrine auto-injector strategy based on innovative new product for the USA
  • Post date
    Release date of six-month interim report (Q2) 2019 for ALK and audio cast
  • Post date
    ALK submits registration application for tree SLIT-tablet in Canada
  • Post date
    ALK obtains European approval for its tree SLIT-tablet against allergic rhinitis
  • Post date
    As ALK prepares to further extend their SLIT-tablet portfolio, tablet formulation is seen as key in delivering consistent positive clinical trial results

Media Relations

Per Plotnikof
Vice President,
Corporate Communications & Investor Relations 
Phone: +45 22612525

Jeppe Ilkjær
Director, Global Media Relations
Corporate Communications & Investor Relations 
Phone: +45 30502014

Journalists are always welcome to contact ALK’s Media Relations team.
Søren Niegel, EVP Commercial Operations
Henrik Jacobi, EVP Research and Development
Søren Jelert, CFO
Christian G. Houghton, EVP Product Supply
Jan Engel, SVP Global Quality
Lisbeth Kirk, SVP HR & Internal Communications
Production facilities, Hørsholm
Production facilities, Hørsholm
Production facilities, Hørsholm
ALK HQ, Hørsholm
Last updated: 2020.01.21